Diluting AD brain homogenate to 0.11 ng/μl ptau to obtain a low tau load sample for comparison produced a nonlinear decrease in seeding levels (Fig. 4A, red), which was more potently inhibited by DA with an IC50 of 3.6 μM (Fig. 4, A and B). Here, MAPT is linked to Alzheimer disease.